Recruitment

Recruitment Status
Recruiting
Estimated Enrollment
Same as current

Summary

Conditions
  • Low Anterior Resection Syndrome
  • Fecal Incontinence
  • Malignant Anal Neoplasm
  • Stage IVA Rectal Cancer AJCC v8
  • Stage IV Rectal Cancer AJCC v8
  • Malignant Bladder Neoplasm
  • Malignant Cervical Neoplasm
  • Malignant Ovarian Neoplasm
  • Malignant Pelvic Neoplasm
  • Malignant Prostate Neoplasm
  • Stage IVC Rectal Cancer AJCC v8
  • Stage IIIB Rectal Cancer AJCC v8
  • Rectal Adenocarcinoma
  • Malignant Uterine Neoplasm
  • Stage IIIC Rectal Cancer AJCC v8
  • Malignant Vaginal Neoplasm
  • Malignant Vulvar Neoplasm
  • Stage IVB Rectal Cancer AJCC v8
  • Stage IIIA Rectal Cancer AJCC v8
  • Stage III Rectal Cancer AJCC v8
Type
Interventional
Phase
Not Applicable
Design
Allocation: N/AIntervention Model: Single Group AssignmentMasking: None (Open Label)Primary Purpose: Supportive Care

Participation Requirements

Age
Between 18 years and 125 years
Gender
Both males and females

Description

PRIMARY OBJECTIVES: I. To investigate the efficacy of sacral nerve stimulator placement in patients with fecal incontinence (FI) or low anterior resection syndrome (LARS) who have previously undergone chemoradiation treatment and/or a restorative partial or complete proctectomy with colorectal or co...

PRIMARY OBJECTIVES: I. To investigate the efficacy of sacral nerve stimulator placement in patients with fecal incontinence (FI) or low anterior resection syndrome (LARS) who have previously undergone chemoradiation treatment and/or a restorative partial or complete proctectomy with colorectal or coloanal anastomosis for cancer treatment as per standard of care (restorative surgery cohort). II. To evaluate the feasibility of sacral nerve stimulator placement in patients with fecal incontinence (FI) or other defecatory dysfunction who have received pelvic radiation treatment without undergoing rectal or other pelvic surgery as per standard of cancer care (radiation only cohort). SECONDARY OBJECTIVES: I. To evaluate the effectiveness of sacral nerve stimulation (SNS) as measured by validated questionnaires in patients with FI or LARS within both patient cohorts. II. To evaluate pelvic floor and sphincter physiology using anorectal manometry (ARM) before and after SNS in patients with FI or LARS within both patient cohorts. III. To assess potential impact of SNS on urinary incontinence measuring a post-void urinary bladder residual and validated urinary symptom questionnaires in both patient cohorts. IV. To assess efficacy of SNS on long-term bowel dysfunction at 1 and 3 years post battery implantation as measured by validated questionnaires for both patient cohorts. OUTLINE: Patients undergo scheduled, elective surgery for placement of the sacral nerve stimulator with external battery pack. After 2 weeks, patients undergo implantation of a subcutaneous internal battery or removal of the leads if the sacral nerve stimulator is working but does not improve symptoms. If the sacral nerve stimulator is not working, it is repositioned and patients return 2 weeks later for implantation of external battery or removal of leads. After completion of study, patients are followed up at 1 month, 1 year, and 3 years.

Tracking Information

NCT #
NCT04066894
Collaborators
National Cancer Institute (NCI)
Investigators
Principal Investigator: Craig A Messick M.D. Anderson Cancer Center